Skip to main content

COVID-19 DDIs Webinar on May 13th

May 07, 2020

COVID-19 DDIs Webinar on May 13th

DDI logo news webinar

Register for our upcoming webinar about drug-drug interactions related to treatments for COVID-19.

When: May 13, 2020 2:00 PM Eastern

Registration linkhttps://uahs.zoom.us/webinar/register/WN_VsdejiJyQ2GvKDbN3GwjpA

Email contact: info@ddi-cds.org

About the webinar: Due to the emerging therapeutic options for COVID-19, we will focus on relevant drug-drug interactions for treatments that have been advocated for treatment of this virus. We recognize this is a rapidly evolving issue and the objectives of our seminar are to highlight important drug safety issues regarding concomitant therapies that may be used in patients exposed to the COVID19 virus.

Drug interaction experts Drs. Philip Hansten and John Horn will provide an overview the various DDIs that may affect the safety and efficacy of products. We will also provide evidence from recent studies concerning the topic.

We invite individuals interested in drug safety as it pertains to  drug-drug interactions to attend this webinar.

This webinar is provided free of charge. Please register here.

More information can be found at:  https://ddi-cds.org/